Delivery Order SPE2DB25D3012-SPE2DB26FWVQP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,104.04 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with the DLA. This award is issued...
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,170.30 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on September 25, 2025, with completion scheduled for September 26, 2025. This competitive delivery order employs firm fixed pricing and carries no set-aside designation. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical procurement needs...
- The Defense Logistics Agency awarded a delivery order valued at $3,386.42 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,525.48 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitive award utilizes a firm fixed-price contract structure with a completion date of December 3, 2025, and involves performance at the vendor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,284.97 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Actemra 400 mg/20 ml vials with a ceiling value of $3,297.92. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Actemra 80 mg/4 mL vials, with a ceiling value of $1,924.58 and an ultimate completion date of December 16, 2025. This non-set-aside, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $6.8K delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This competitive, firm fixed-price contract is set to conclude on December 22, 2025, with performance taking place at the vendor's headquarters in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVQPDelivery Order
The Defense Logistics Agency awarded a $21,612.59 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order issued under a larger contract vehicle rather than a standalone agreement. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad portfolio of pharmaceuticals and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability in meeting DLA requirements through open competition across numerous therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 10/28/25 |